APA (7th ed.) Citation

O, T., Y, O., B, D., D, Y., E, B., M, K., . . . G, D. D. (2023). A two-step purification platform for efficient removal of Fab-related impurities: A case study for Ranibizumab. Heliyon, 9(11), e21001. https://doi.org/10.1016/j.heliyon.2023.e21001

Chicago Style (17th ed.) Citation

O, Tatli, et al. "A Two-step Purification Platform for Efficient Removal of Fab-related Impurities: A Case Study for Ranibizumab." Heliyon 9, no. 11 (2023): e21001. https://doi.org/10.1016/j.heliyon.2023.e21001.

MLA (9th ed.) Citation

O, Tatli, et al. "A Two-step Purification Platform for Efficient Removal of Fab-related Impurities: A Case Study for Ranibizumab." Heliyon, vol. 9, no. 11, 2023, p. e21001, https://doi.org/10.1016/j.heliyon.2023.e21001.